We provide a listing of all relevant press news, please make your selection.
Posttranslational Modifications of Proteins and the Consequences for Therapeutic Use was the focus of 2010's Science to Market Conference in Vienna
With the "Science to Market" conference EAPB aimes at contributing to measures countering the European commercialization deficiency in biotechnology research and promoting the industrial application of scientific inventions.
EAPB's contribution to PharmSciFair 2009 is mentioned in EUFEPS newsletter.
To bridge the gap between academic research and industrial application was the goal of the first Science to Market organized by EAPB in cooperation with Dechema and Biotechnica.
Vogel Life Science Media launches 'NewDrugs - a new print medium for international research in pharma biotechnology'.